To amend subsection (q) of section 505 of the Federal Food, Drug, and Cosmetic Act to clarify the process for denying certain petitions whose primary purpose is to delay the approval of an application submitted under subsection (b)(2) or (j) of such section 505, and for other purposes.
119-HR-8908119th CongressIntroduced May 19, 2026
Market Probability
No market
Status
Introduced
Committee
Floor Vote
Other Chamber
Signed
Referred to the House Committee on Energy and Commerce.
Sponsor
Rep. Sorensen, Eric [D-IL-17](D-IL-17)1 cosponsor
Actions (3)
Referred to the House Committee on Energy and Commerce.
May 19, 2026House floor actions
Introduced in House
May 19, 2026Library of Congress
Introduced in House
May 19, 2026Library of Congress